Related Experiment Videos

Pneumococcal bacteremia at a medical/surgical hospital for adults between 1975 and 1980

Insights

Pneumococcal bacteremia primarily affects adults with underlying diseases. Patients treated with penicillin alone had better outcomes, and vaccination is recommended for high-risk individuals.

Area of Science:

  • Infectious Diseases
  • Bacteriology
  • Vaccinology

Background:

  • Pneumococcal bacteremia is a serious infection.
  • Understanding risk factors and outcomes is crucial for patient management.

Purpose of the Study:

  • To review episodes of pneumococcal bacteremia.
  • To identify patient demographics, underlying conditions, and treatment outcomes.
  • To assess the role of pneumococcal vaccination.

Main Methods:

  • Retrospective review of 72 pneumococcal bacteremia cases.
  • Analysis of patient age, sex, underlying diseases, and complications.
  • Correlation of outcomes with comorbidities, asplenia, and antimicrobial treatment.
  • Serotyping of isolates to compare with available pneumococcal vaccine.

Main Results:

  • Pneumococcal bacteremia occurred in 4-5% of all bacteremias.
  • Most patients (87%) had underlying diseases; 78% were community-acquired.
  • Overall mortality was 43%, higher in asplenic patients (83%).
  • Complications occurred in 44% of patients.
  • Penicillin monotherapy was associated with better outcomes.
  • 67% of isolates matched serotypes in the 14-valent pneumococcal vaccine.

Conclusions:

  • Pneumococcal bacteremia predominantly affects adults with underlying conditions.
  • Factors influencing mortality include comorbidities, complications, and asplenia.
  • Penicillin monotherapy appears to be an effective treatment.
  • Pneumococcal vaccination should be considered for high-risk populations.

Related Concept Videos